Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice

Hypertension

Volumn 47, Issue 2, 2006, Pages 288-295

  Bek, Martin J ^a,b   Wang, Xiaoyan ^a   Asico, Laureano D ^a   Jones, John E ^a   Zheng, Shaopeng ^a   Li, XiaoXi ^a   Eisner, Gilbert M ^a   Grandy, David K ^c   Carey, Robert M ^d   Soares da Silva, Patricio ^e   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e Institute of Histology and Embryology   (Portugal)

Author keywords

Angiotensin II; Dopamine; Endothelin; Hypertension; Mice; Receptors, angiotensin II; Vasopressins

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DOPAMINE 4 RECEPTOR; LOSARTAN; RENIN;

ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HOMOGENATE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HOMOGENATE; HYPERTENSION; KIDNEY FUNCTION; KIDNEY HOMOGENATE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PHENOTYPE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; BRAIN; CATECHOLS; HYPERTENSION; KIDNEY; LOSARTAN; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NA(+)-K(+)-EXCHANGING ATPASE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D4; RENIN; SODIUM;

EID: 32044442974     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000198427.96225.36     Document Type: Article

References (54)

1. Pickering G. Hypertension: definitions, natural histories, and consequences. In: Hypertension, Pathophysiology, Diagnosis, and Management. Laragh JH, Brenner BM, eds. New York: Raven Press; 1995:3-22.
2. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1999;272:676-680.
3. Jose PA, Eisner GM, Felder RA. The renal dopamine receptors in health and disease. Pharmacol Ther. 1998;80:149-182.
4. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension. 1998;32:187-197.
5. van den Buuse M. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin Exp Pharmacol Physiol. 1998;25:661-668.
6. Sowers JR, Viosca SP, Windsor C, Korenman SG. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J Endocrinol Invest. 1983; 6:9-15.
7. Carey RM, Sen S. Recent progress in the control of aldosterone secretion. Recent Prog Horm Res. 1986;42:251-296.
8. Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br J Pharmacol. 1995;114:1403-1413.
9. Roitman MF, Schafe GE, Thiele TE, Bernstein IL. Dopamine and sodium appetite: antagonists suppress sham drinking of NaCl solutions in the rat. Behav Neurosci. 1997;111:606-611.
10. 1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996;97: 2283-2288.
11. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension. 2001;38:303-308.
12. Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, Pocchiari F, Felder RA, Eisner GM, Jose PA. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest. 1998;102:493-498.
13. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS 3rd, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci. 2002;22:10801-10810.
14. Ricci A, Marchal-Victorion S, Bronzetti E, Parini A, Amenta F, and Tayebati SK. Dopamine D4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. J Histochem Cytochem. 2002;50:1091-1096.
15. Sun D, Wilborn TW, Schafer JA. Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am J Physiol. 1998;275:F742-F751.
16. O'Malley KL, Harmon S, Tang L, Todd RD. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 1992;4:137-146.
17. Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Mol Psychiatry. 1998;3:528-533.
18. Stein CM, Song Y, Elston RC, Jun G, Tiwari HK, Iyengar SK. Structural equation model-based genome scan for the metabolic syndrome. BMC Genet. 2003;31(Suppl 1):S99.
19. Ishimitsu T, Hosoya K, Tsukada K, Minami J, Futoh Y, Ono H, Ohrui M, Hino J, Kangawa K, Matsuoka H. Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension. Hypertension. 2001;38:9-12.
20. Sen S, Nesse R, Sheng L, Stoltenberg SF, Gleibmerman L, Burmeister M, Weder AB. Association between a dopamine 4 receptor polymorphism and blood pressure in the GenNet study: Evidence for a gene-age interaction. Council for High Blood Pressure Research. 2003;P208 (abstracts).
21. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell. 1997;19:90:991-1001.
22. Kawada N, Solis G, Ivey N, Connors S, Dennehy K, Modlinger P, Hamel R, Kawada JT, Imai E, Langenbach R, Welch WJ, Wilcox CS. Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction. Hypertension. 2005;45:1131-1138.
23. +)-adenosine triphosphatase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo. J Pharmacol Exp Ther. 1984;228:304-311.
24. Vieira-Coelho MA, Serrao P, Guimaraes JT, Pestana M, Soares-da-Silva P. Concerted action of dopamine on renal and intestinal Na+-K+-ATPase in the rat remnant kidney. Am J Physiol Renal Physiol. 2000;279:F1033-F1044.
25. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA. 1998;95:14552-14557.
26. Wang X, Masilamani S, Nielsen J, Kwon T, Brooks H, Nielsen S, Knepper MA. The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. J Clin Invest. 2001;108: 215-222.
27. Park SH, Han HJ. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells. Am J Physiol Renal Physiol. 2002;282:F228-F237.
28. 3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension. 2003;41:724-729.
29. 1 receptor interaction in spontaneously hypertensive rats. Hypertension. 2003;42:787-792.
30. Hickman-Davis JM. Implications of mouse genotype for phenotype. News Physiol Sci. 2001;16:9-22.
31. Wolfer DP, Crusio WE, Lipp HP. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci. 2002;25:336-340.
32. Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ, Levine MS, Grandy DK Grandy DK. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci. 2001;21:3756-3763.
33. Hyde TM, Knable MB, Murray AM. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse. 1996;24:224-232.
34. Defagot MC, Malchiodi EL, Villar MJ, Antonelli MC. Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res. 1997;45:1-12.
35. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res. 1997;752:26-34.
36. Carey RM. Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens. 2005;14:67-71.
37. Fink GD. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol. 1997;24:91-95.
38. Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Regul Pept. 1998;78:1-11.
39. Ferrario CM. Neurogenic actions of angiotensin II. Hypertension. 1983;5:V73-V79.
40. 1 receptors mediate excitatory inputs to rostral ventrolateral medullar pressor neurons from hypothalamus. Hypertension. 1999;34:1301-1307.
41. Unger T, Badoer E, Ganten D, Lang RE, Rettig R. Brain angiotensin: pathways and pharmacology. Circulation. 1988;77:I40-54.
42. Tseng CJ, Chou LL, Ger LP, Tung CS. Cardiovascular effects of angiotensin III in brainstem nuclei of normotensive and hypertensive rats. J Pharmacol Exp Ther. 1994;268:558-564.
43. Yamamoto K, Ueno Y, Arita M, Suruda H, Hano T, Masuyama Y. Contributions of the sympathetic nervous system, vasopressin and baroreceptor function in brain angiotensin II excess-induced hypertension in the dog. Clin Exp Hypertens A. 1988;10(Suppl 1):309-316.
44. 1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats. Brain Res Dev Brain Res. 1993;71:193-199.
45. Brooks VL, Osborn JW. Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis. Am J Physiol. 1995;268: R1343-R1358.
46. Hasser EM, Cunningham JT, Sullivan MJ, Curtis KS, Blaine EH, Hay M. Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II. Clin Exp Pharmacol Physiol. 2000;27:432-436.
47. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol. 2003;81:533-541.
48. Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens. 2000;9:157-164.
49. Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, Masaki T, de Wit D, Yanagisawa M, Kimura S. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol. 1997;120:1427-1430.
50. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A. Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens. 2000;22:277-288.
51. Schafer JA, Li L, Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol Scand. 2000;168:239-244.
52. Saito O, Ando Y, Kusano E, Asano Y. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol. 2001;281:F114-F122.
53. -/- mice. Am J Physiol Renal Physiol. 2003;284:F1274-F1279.
54. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10(Suppl 12):S258-S265.